Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 84

1.

Homocysteine, grey matter and cognitive function in adults with cardiovascular disease.

Ford AH, Garrido GJ, Beer C, Lautenschlager NT, Arnolda L, Flicker L, Almeida OP.

PLoS One. 2012;7(3):e33345. doi: 10.1371/journal.pone.0033345. Epub 2012 Mar 7.

2.

Homocysteine and cognitive function in the elderly: the Rotterdam Scan Study.

Prins ND, Den Heijer T, Hofman A, Koudstaal PJ, Jolles J, Clarke R, Breteler MM; Rotterdam Scan Study.

Neurology. 2002 Nov 12;59(9):1375-80.

PMID:
12427887
3.

Associations between elevated homocysteine, cognitive impairment, and reduced white matter volume in healthy old adults.

Feng L, Isaac V, Sim S, Ng TP, Krishnan KR, Chee MW.

Am J Geriatr Psychiatry. 2013 Feb;21(2):164-72. doi: 10.1016/j.jagp.2012.10.017. Epub 2013 Jan 22.

PMID:
23343490
4.

Homocysteine as a risk factor for cognitive impairment in stroke patients.

Sachdev PS, Valenzuela MJ, Brodaty H, Wang XL, Looi J, Lorentz L, Howard L, Jones M, Zagami AS, Gillies D, Wilcken DE.

Dement Geriatr Cogn Disord. 2003;15(3):155-62.

PMID:
12584431
5.

Association of homocysteine with plasma amyloid beta protein in aging and neurodegenerative disease.

Irizarry MC, Gurol ME, Raju S, Diaz-Arrastia R, Locascio JJ, Tennis M, Hyman BT, Growdon JH, Greenberg SM, Bottiglieri T.

Neurology. 2005 Nov 8;65(9):1402-8.

PMID:
16275827
6.

Homocysteine, depression and cognitive function in older adults.

Ford AH, Flicker L, Singh U, Hirani V, Almeida OP.

J Affect Disord. 2013 Nov;151(2):646-51. doi: 10.1016/j.jad.2013.07.012. Epub 2013 Aug 5.

PMID:
23928176
7.

Homocysteine, white matter hyperintensities, and cognition in healthy elderly people.

Dufouil C, Alpérovitch A, Ducros V, Tzourio C.

Ann Neurol. 2003 Feb;53(2):214-21.

PMID:
12557288
8.

Homocysteine, progression of ventricular enlargement, and cognitive decline: the Second Manifestations of ARTerial disease-Magnetic Resonance study.

Jochemsen HM, Kloppenborg RP, de Groot LC, Kampman E, Mali WP, van der Graaf Y, Geerlings MI; SMART Study Group.

Alzheimers Dement. 2013 May;9(3):302-9. doi: 10.1016/j.jalz.2011.11.008. Epub 2012 Aug 3.

PMID:
22863909
9.

Homocysteine level and cognitive function in patients with arterial disease: the second manifestations of ARTerial Disease Study.

van Raamt AF, Kalmijn S, Mali WP, van Zandvoort MJ, van der Graaf Y; SMART Study Group.

J Am Geriatr Soc. 2006 Apr;54(4):575-9.

PMID:
16686865
10.

Increased total homocysteine level is associated with clinical status and severity of white matter changes in symptomatic patients with subcortical small vessel disease.

Pavlovic AM, Pekmezovic T, Obrenovic R, Novakovic I, Tomic G, Mijajlovic M, Sternic N.

Clin Neurol Neurosurg. 2011 Nov;113(9):711-5. doi: 10.1016/j.clineuro.2011.07.004. Epub 2011 Jul 29.

PMID:
21802199
11.

Lifestyle and cardiovascular disease risk factors as determinants of total cysteine in plasma: the Hordaland Homocysteine Study.

El-Khairy L, Ueland PM, Nygård O, Refsum H, Vollset SE.

Am J Clin Nutr. 1999 Dec;70(6):1016-24.

12.

Plasma homocysteine and vascular disease in psychogeriatric patients.

Nilsson K, Gustafson L, Hultberg B.

Dement Geriatr Cogn Disord. 2006;21(3):148-54. Epub 2006 Jan 2.

PMID:
16391477
13.

Homocysteine and cerebral small vessel disease in patients with symptomatic atherosclerotic disease. The SMART-MR study.

Kloppenborg RP, Nederkoorn PJ, van der Graaf Y, Geerlings MI.

Atherosclerosis. 2011 Jun;216(2):461-6. doi: 10.1016/j.atherosclerosis.2011.02.027. Epub 2011 Feb 24.

14.

Changes in lifestyle and plasma total homocysteine: the Hordaland Homocysteine Study.

Nurk E, Tell GS, Vollset SE, Nygård O, Refsum H, Nilsen RM, Ueland PM.

Am J Clin Nutr. 2004 May;79(5):812-9.

15.

Plasma homocysteine is elevated in elderly patients with memory complaints and vascular disease.

Nilsson K, Gustafson L, Hultberg B.

Dement Geriatr Cogn Disord. 2007;23(5):321-6. Epub 2007 Mar 19.

PMID:
17374950
16.

Plasma homocysteine and microvascular and macrovascular complications in type 1 diabetes: a cross-sectional nested case-control study.

Soedamah-Muthu SS, Chaturvedi N, Teerlink T, Idzior-Walus B, Fuller JH, Stehouwer CD; Eurodiab ProspectivE Complications Study Group.

J Intern Med. 2005 Nov;258(5):450-9.

17.

Elevated plasma homocysteine levels in centenarians are not associated with cognitive impairment.

Ravaglia G, Forti P, Maioli F, Vettori C, Grossi G, Bargossi AM, Caldarera M, Franceschi C, Facchini A, Mariani E, Cavalli G.

Mech Ageing Dev. 2000 Dec 20;121(1-3):251-61.

PMID:
11164478
18.

Plasma homocysteine levels, cerebrovascular risk factors, and cerebral white matter changes (leukoaraiosis) in patients with Alzheimer disease.

Hogervorst E, Ribeiro HM, Molyneux A, Budge M, Smith AD.

Arch Neurol. 2002 May;59(5):787-93.

PMID:
12020261
19.

Association of plasma total homocysteine levels with subclinical brain injury: cerebral volumes, white matter hyperintensity, and silent brain infarcts at volumetric magnetic resonance imaging in the Framingham Offspring Study.

Seshadri S, Wolf PA, Beiser AS, Selhub J, Au R, Jacques PF, Yoshita M, Rosenberg IH, D'Agostino RB, DeCarli C.

Arch Neurol. 2008 May;65(5):642-9. doi: 10.1001/archneur.65.5.642.

20.

Homocysteine and cognitive impairment. Relation with diagnosis and neuropsychological performance.

Sala I, Belén Sánchez-Saudinós M, Molina-Porcel L, Lázaro E, Gich I, Clarimón J, Blanco-Vaca F, Blesa R, Gómez-Isla T, Lleó A.

Dement Geriatr Cogn Disord. 2008;26(6):506-12. doi: 10.1159/000173710. Epub 2008 Nov 20.

PMID:
19023204

Supplemental Content

Support Center